NASDAQ
FibroGen, Inc. (FGEN) has a revenue compound annual growth rate of -48.42% over 5 years and -28.36% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.